Skip to main content

Advertisement

SpringerLink
Log in

Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab

  • Letter to the Editor
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lattanzi S, Logullo F, Di Bella P et al (2014) Multiple sclerosis, solitary sclerosis or something else? Mult Scler 20:1819–1824

    Article  Google Scholar 

  2. Lattanzi S, Cagnetti C, Danni M et al (2017) Oral and intravenous steroids for multiple sclerosis relapse: a systematic review and meta-analysis. J Neurol 264:1697–1704

    Article  CAS  Google Scholar 

  3. Crayton HJ, Rossman HS (2006) Managing the symptoms of multiple sclerosis: a multimodal approach. Clin Ther 28:445–460

    Article  Google Scholar 

  4. Mulero P, Midaglia L, Montalban X (2018) Ocrelizumab: a new milestone in multiple sclerosis therapy. Ther Adv Neurol Disord. https://doi.org/10.1177/1756286418773025

    Article  PubMed  PubMed Central  Google Scholar 

  5. Winkelmann A, Loebermann M, Reisinger EC, Hartung HP, Zettl UK (2016) Disease-modifying therapies and infectious risks in multiple sclerosis. Rev Neurol 12:217–233

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurological Clinic, Department of Experimental and Clinical Medicine, Marche Polytechnic University, Via Conca 71, 60020, Ancona, Italy

    Simona Lattanzi, Giulia Carlini, Maria Cristina Acciarri, Maura Danni & Mauro Silvestrini

Authors
  1. Simona Lattanzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giulia Carlini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Cristina Acciarri
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maura Danni
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mauro Silvestrini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simona Lattanzi.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflict of interest.

Ethical standards

The patient provided informed oral and written consent in accordance with specific national laws and the ethics standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lattanzi, S., Carlini, G., Acciarri, M.C. et al. Parvovirus B19 infection in a patient with multiple sclerosis treated with ocrelizumab. Acta Neurol Belg 120, 231–232 (2020). https://doi.org/10.1007/s13760-019-01227-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-019-01227-y

Search

Navigation